[Communicating about the flare-up and its treatment]

Marie Guillet1

  • 1Service neurologie, centre hospitalier universitaire de Rennes, 2 rue Henri-le-Guilloux, 35000 Rennes, France; Association Neuro-Bretagne, centre hospitalier universitaire de Rennes, 2 rue Henri-le-Guilloux, 35000 Rennes, France.

Insights

Identifying relapsing-remitting multiple sclerosis relapses is crucial for patient support. A relapse involves new, lasting neurological symptoms for over 24 hours, excluding fever or infection, within 30 days of the prior event.

Area of Science:

  • Neuroimmunology
  • Clinical Neurology

Context:

  • Relapsing-remitting multiple sclerosis (RRMS) is characterized by distinct episodes of neurological dysfunction.
  • Accurate identification of these episodes is essential for effective patient management and treatment strategies.

Purpose:

  • To define the diagnostic criteria for a multiple sclerosis relapse.
  • To provide clear guidelines for healthcare professionals in identifying relapse events.

Summary:

  • A multiple sclerosis relapse is defined as new neurological symptoms lasting at least 24 hours.
  • These symptoms must be permanent, without fever or infection, and occur within 30 days of a previous relapse.
  • Symptom presentation varies based on the affected area of the central nervous system.

Impact:

  • Facilitates timely and appropriate clinical interventions for patients experiencing relapses.
  • Improves the consistency of relapse diagnosis across different healthcare settings.
  • Supports research into the mechanisms and management of multiple sclerosis progression.

Related Concept Videos

Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
219
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
165
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
165
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
212
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
716
Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing01:23

Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing

Focusing involves centering a conversation on a message's critical elements or concepts. Focusing is valuable if the talk is vague or patients begin to repeat themselves. Sometimes, when patients are asked about their symptoms, they may go off-topic and try to tell their entire life story. Respectfully, the nurse should bring the conversation back into focus.
This therapeutic technique can also be used when a patient brings up pertinent information during a health-related conversation. The...
8.3K